The Lithotripsy market is expected to reach USD 2,100 Million by 2030 at 5.80% CAGR during the forecast period 2022-2030. The global Lithotripsy market is growing rapidly, gaining colossal prominence owing to the augmenting prevalence of kidney stones. Attributing to the technological advancements transpired in the medical science, the market has grown exponentially, witnessing the emergence of novel treatment procedures, medications & surgeries. 

Also, the risk factors causing kidney stones are contributing to the market growth substantially. Kidney stones could cause due to many reasons, but the one that tops over other reasons is heady lifestyle coupled with the low intake of water. 

Other risk factors for kidney stones are chronic inflammation of the bowel, obesity, and diabetes. Besides, factors such as diets those are high in protein and sodium but low in calcium, high blood pressure, and conditions that affect the rate of the calcium absorption in the body, chronic diarrhea. Etc. also, act as risk factors for the occurrence of kidney stone. 

Also, the prevalence of UTI (urinary tract infections), due to the presence of higher ammonia and pH in urine accounts for a key risk factor for kidney stones. The Prevalence of conditions mentioned above fuel the chances of developing the kidney stones, in turn, escalate the market for the Lithotripsy on the global platform. 

Global Lithotripsy Market – Segments

The MRFR analysis is segmented into three key dynamics;

By Types                           : Extracorporeal shock wave lithotripsy (ESWL), Intracorporeal (Endoscopic Lithotripsy, Laser Lithotripsy, Electrohydraulic Lithotripsy, Mechanical Lithotripsy, and Ultrasonic Lithotripsy.), and Percutaneous lithotripsy, among others.

By End-Users     : Hospitals and clinics, Research laboratories, and Academic Institutes, among others.

By Regions                        :  North America, Europe, APAC and the Rest-of-the-World.

Global Lithotripsy Market – Regional Analysis 

Geographically, North America accounts for the leading market for Lithotripsy, possessing a substantial market share, followed by the markets of Europe & Asia Pacific, respectively. The significant contribution from the growing market in the US, backed by the high expenditure on healthcare acts as a tailwind for the market growth. Moreover, increasing prevalence of kidney diseases and rising demand for treatment measures provide impetus to the market growth. 

On the other hand, Europe, the world’s second-largest market for Lithotripsy is fostered by the high per capita income and the well-proliferated healthcare sector in the region. The market growth in the countries such as Germany & France pushes the market growth in the region in the large scale. With the increasing investment in health care and rising number of patients with renal diseases, the market is projected to register a phenomenal CAGR 

The Asia Pacific market for the Lithotripsy is estimated to observe an exponential growth.  India and China with their huge patient’s pool and the burgeoning medical treatment market will lead the market growth in the region. Vietnam, Thailand, and Malaysia among the other South East Asian countries are projected to contribute significantly to the regional market growth. With the growing Medical Tourism markets in India & Malaysia, the APAC region will register a healthy CAGR during the review period.

Key Players:

Some of the fervent key players driving the market include DIREX, S.L. (Spain), Boston Scientific (US), Dornier MedTech. (Germany), Elmed Electronics & Medical Industry & Trade Inc. (Turkey), EDAP TMS (France), Jena Med Tech GmbH (Germany), Olympus Corporation (Japan), Medispec LTD (US), Siemens Healthcare GmbH (Germany), and STORZ MEDICAL AG (Switzerland)

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.